Largest Healthcare GPO in Canada - HealthPRO Procurement Services, Inc. -
Expands Contract to Include RENASYS(TM) Negative Pressure Wound Therapy
(NPWT) Products From Smith & Nephew for Gauze Category

The RENASYS - G (Gauze) Negative Pressure Wound Therapy (NPWT) System
offers clinicians flexibility of choice and a proven alternative to treat
wounds that are difficult to dress with traditional foam based therapies.

ST. PETERSBURG, FL, and MISSISSAUGA, ON, Dec. 1 /CNW/ - Today, Smith & Nephew's Advanced Wound Management division (LSE: SN) (NYSE: SNN) and HealthPRO Procurement Services, Inc., the largest healthcare group purchasing organization (GPO) in Canada, announced a new contract which expands access for RENASYS - G NPWT Systems to all HealthPRO shareholders, who are committed to the contact, offering more choice in NPWT for clinicians and patients.

The new five-year contract will go into effect on December 1, 2010. HealthPRO has 251 shareholders with members located in British Columbia, Alberta, Manitoba, Ontario, Nova Scotia, Newfoundland and Labrador, Nunavut, Northwest Territories and Yukon and manages $1.54 billion in contract volume.

"HealthPRO is committed to providing quality products and services to our members. We recognize the need to offer an expanded list of treatment modalities in Negative Pressure Wound Therapy, and can now offer gauze as a treatment modality option in addition to foam," said Denise Shoesmith, Vice President of Materials Management at HealthPRO.

"We are very pleased to be able to bring HealthPRO's clinicians flexibility of choice in NPWT with our RENASYS - G portfolio," said Tom Dugan, President, North America, Smith & Nephew Advanced Wound Management. "Our RENASYS-G NPWT system offers clinicians a proven alternative to treat wounds that are difficult to dress with traditional foam based therapies, while at the same time enhancing patient comfort," stated Mr. Dugan.

The RENASYS (NPWT) line of products treat a wider range of wounds, improve patient quality of life, and reduce overall utilization costs with a choice of gauze and foam dressing interfaces, quiet and intuitive devices, and customer-oriented clinical support and education.

For more information regarding Smith & Nephew, please visit our Web site at http://www.myrenasys.com

About Smith & Nephew

Smith & Nephew is a global medical technology business with global leadership positions in Orthopaedics; including Reconstruction, Trauma and Clinical Therapies; Endoscopy; including Sports Medicine; and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.

Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company has distribution channels, purchasing agents and buying entities in over 90 countries worldwide. Annual sales in 2009 were nearly $3.8 billion.

About HealthPRO Procurement Services Inc.

HealthPRO is a Canadian corporation, formed in 1996, owned by and responsible to its shareholders/customers. The HealthPRO mandate is to provide shareholders with high quality, cost effective procurement support, and unique services, such as product standardization, supply chain management tools, networks for best practices and clinical education. Current product and service categories include Pharmacy Services, Clinical Services and Clinical Specialties, Energy Management, Nutrition & Food Services and Special Services.

For more information: www.healthprocanada.com

Caution Regarding Forward-Looking Statements

This document contains certain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payors and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; strategic actions, including acquisitions and dispositions and our success in integrating acquired businesses; and numerous other matters that affect us or our markets, including those of a political, economic, business or competitive nature. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.

Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations.

(TM) Trademark of Smith & Nephew. Certain marks registered US Patent and Trademark Office.

For further information: Press, Judye Reed, Director of Marketing Communications, [phone], or Other Inquiries, Tom Dugan, President, North America, [phone], both of Smith & Nephew Advanced Wound Management; or Investors, Phil Cowdy, Director - Investor Relations of Smith & Nephew plc, + 44 (0) 207 401 7646 Web Site: http://www.myrenasys.com http://www.healthprocanada.com